$PETS
PETMED EXPRESS INC

2017 Q3 Form 10-Q Financial Statement

#000143774917017912 Filed on October 31, 2017

View on sec.gov

Income Statement

Concept 2017 Q3 2016 Q3
Revenue $66.71M $60.79M
YoY Change 9.74% 7.16%
Cost Of Revenue $43.23M $42.73M
YoY Change 1.18% 13.0%
Gross Profit $23.48M $18.06M
YoY Change 29.98% -4.47%
Gross Profit Margin 35.2% 29.71%
Selling, General & Admin $10.70M $10.13M
YoY Change 5.63% -12.97%
% of Gross Profit 45.57% 56.08%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $527.0K $204.0K
YoY Change 158.33% 7.37%
% of Gross Profit 2.24% 1.13%
Operating Expenses $11.23M $10.33M
YoY Change 8.69% -12.65%
Operating Profit $12.25M $7.731M
YoY Change 58.43% 9.19%
Interest Expense $140.0K $30.00K
YoY Change 366.67% -50.0%
% of Operating Profit 1.14% 0.39%
Other Income/Expense, Net $392.0K $55.00K
YoY Change 612.73%
Pretax Income $12.64M $7.786M
YoY Change 62.34% 9.05%
Income Tax $3.880M $2.887M
% Of Pretax Income 30.7% 37.08%
Net Earnings $8.760M $4.899M
YoY Change 78.81% 8.87%
Net Earnings / Revenue 13.13% 8.06%
Basic Earnings Per Share $0.43 $0.24
Diluted Earnings Per Share $0.43 $0.24
COMMON SHARES
Basic Shares Outstanding 20.35M 20.23M
Diluted Shares Outstanding 20.44M 20.38M

Balance Sheet

Concept 2017 Q3 2016 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $68.40M $51.90M
YoY Change 31.79% -10.21%
Cash & Equivalents $68.44M $51.90M
Short-Term Investments
Other Short-Term Assets $1.100M $6.500M
YoY Change -83.08% 182.61%
Inventory $23.00M $14.80M
Prepaid Expenses
Receivables $2.012M $1.400M
Other Receivables $0.00 $0.00
Total Short-Term Assets $94.57M $74.60M
YoY Change 26.76% -13.36%
LONG-TERM ASSETS
Property, Plant & Equipment $29.46M $20.60M
YoY Change 42.99% 1371.43%
Goodwill
YoY Change
Intangibles $860.0K
YoY Change
Long-Term Investments
YoY Change
Other Assets $500.0K
YoY Change 400.0%
Total Long-Term Assets $30.32M $21.90M
YoY Change 38.43% 852.17%
TOTAL ASSETS
Total Short-Term Assets $94.57M $74.60M
Total Long-Term Assets $30.32M $21.90M
Total Assets $124.9M $96.50M
YoY Change 29.41% 9.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.38M $6.100M
YoY Change 70.1% -16.44%
Accrued Expenses $2.900M $2.400M
YoY Change 20.83% 26.32%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $19.26M $8.600M
YoY Change 123.9% -6.52%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $19.26M $8.600M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $20.56M $8.600M
YoY Change 139.06% -6.52%
SHAREHOLDERS EQUITY
Retained Earnings $96.34M
YoY Change
Common Stock $21.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $104.3M $88.00M
YoY Change
Total Liabilities & Shareholders Equity $124.9M $96.50M
YoY Change 29.41% 9.16%

Cashflow Statement

Concept 2017 Q3 2016 Q3
OPERATING ACTIVITIES
Net Income $8.760M $4.899M
YoY Change 78.81% 8.87%
Depreciation, Depletion And Amortization $527.0K $204.0K
YoY Change 158.33% 7.37%
Cash From Operating Activities $4.400M $14.68M
YoY Change -70.03% 354.49%
INVESTING ACTIVITIES
Capital Expenditures -$310.0K -$3.260M
YoY Change -90.49% 4557.14%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$310.0K -$3.260M
YoY Change -90.49% 3975.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -4.180M -3.840M
YoY Change 8.85% 4.92%
NET CHANGE
Cash From Operating Activities 4.400M 14.68M
Cash From Investing Activities -310.0K -3.260M
Cash From Financing Activities -4.180M -3.840M
Net Change In Cash -90.00K 7.580M
YoY Change -101.19% -1586.27%
FREE CASH FLOW
Cash From Operating Activities $4.400M $14.68M
Capital Expenditures -$310.0K -$3.260M
Free Cash Flow $4.710M $17.94M
YoY Change -73.75% 443.64%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2017-09-30
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2017Q3 pets Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
2871000
CY2017Q1 pets Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
2475000
pets Prepaid Property And Equipment In Current Assets
PrepaidPropertyAndEquipmentInCurrentAssets
pets Prepaid Property And Equipment In Current Assets
PrepaidPropertyAndEquipmentInCurrentAssets
5815000
CY2017Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
10376000
CY2017Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
15221000
CY2017Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2012000
CY2017Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1808000
CY2017Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
6008000
CY2017Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
659000
CY2017Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7952000
CY2017Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6806000
CY2017Q3 us-gaap Advertising Expense
AdvertisingExpense
4526000
CY2016Q3 us-gaap Advertising Expense
AdvertisingExpense
4382000
us-gaap Advertising Expense
AdvertisingExpense
10818000
us-gaap Advertising Expense
AdvertisingExpense
10142000
CY2017Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
31000
CY2017Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
27000
CY2017Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
79200
CY2016Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
30000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
79200
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
30000
CY2017Q3 us-gaap Assets
Assets
124882000
CY2017Q1 us-gaap Assets
Assets
112809000
CY2017Q3 us-gaap Assets Current
AssetsCurrent
94566000
CY2017Q1 us-gaap Assets Current
AssetsCurrent
81785000
CY2017Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
30316000
CY2017Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
31024000
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
dei Entity Central Index Key
EntityCentralIndexKey
0001040130
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
PETMED EXPRESS INC
dei Trading Symbol
TradingSymbol
pets
dei Entity Voluntary Filers
EntityVoluntaryFilers
No
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
CY2017Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
20604307
CY2017Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
68443000
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
58730000
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
37639000
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
51896000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
9713000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
14257000
CY2017Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.20
CY2016Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.19
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.40
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.38
CY2017Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2017Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2017Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20604000
CY2017Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20526000
CY2017Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20604000
CY2017Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20526000
CY2017Q3 us-gaap Common Stock Value
CommonStockValue
21000
CY2017Q1 us-gaap Common Stock Value
CommonStockValue
21000
CY2017Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
8760000
CY2016Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4899000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
18036000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
11493000
CY2017Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
43232000
CY2016Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
42727000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
95424000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
92762000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
216000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
364000
CY2017Q3 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
1304000
CY2017Q1 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
1088000
us-gaap Depreciation
Depreciation
1058000
us-gaap Depreciation
Depreciation
398000
CY2017Q3 us-gaap Depreciation
Depreciation
527000
CY2016Q3 us-gaap Depreciation
Depreciation
204000
CY2017Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.43
CY2016Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.24
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.89
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.57
CY2017Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.43
CY2016Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.24
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.88
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.56
CY2017Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.307
CY2016Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.371
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.341
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.371
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
115000
CY2017Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6178000
CY2016Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5747000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12404000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11845000
CY2017Q3 us-gaap Gross Profit
GrossProfit
23479000
CY2016Q3 us-gaap Gross Profit
GrossProfit
18064000
us-gaap Gross Profit
GrossProfit
50944000
us-gaap Gross Profit
GrossProfit
40516000
CY2017Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
12640000
CY2016Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7786000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
27380000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
18267000
CY2017Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3880000
CY2016Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2887000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9344000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6774000
us-gaap Income Taxes Paid
IncomeTaxesPaid
3780000
us-gaap Income Taxes Paid
IncomeTaxesPaid
6186000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-4845000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1143000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
250000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
5349000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
411000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
335000
us-gaap Increase Decrease In Finished Goods And Work In Process Inventories
IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories
2777000
us-gaap Increase Decrease In Finished Goods And Work In Process Inventories
IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories
-10765000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
87000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1764000
us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
-222000
CY2017Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
10000
CY2016Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
10000
us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
10000
us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
10000
CY2017Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
78000
CY2016Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
133000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
111000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
137000
CY2017Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
860000
CY2017Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
860000
CY2017Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
23005000
CY2017Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
20228000
CY2017Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
143000
CY2016Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
32000
us-gaap Investment Income Interest
InvestmentIncomeInterest
226000
us-gaap Investment Income Interest
InvestmentIncomeInterest
60000
CY2017Q3 us-gaap Liabilities
Liabilities
20559000
CY2017Q1 us-gaap Liabilities
Liabilities
19443000
CY2017Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
124882000
CY2017Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
112809000
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
202000
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
144000
CY2017Q3 us-gaap Liabilities Current
LiabilitiesCurrent
19255000
CY2017Q1 us-gaap Liabilities Current
LiabilitiesCurrent
18355000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-8240000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-7669000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-350000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5859000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
18303000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
27785000
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
8760000
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
4899000
us-gaap Net Income Loss
NetIncomeLoss
18036000
us-gaap Net Income Loss
NetIncomeLoss
11493000
CY2017Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
392000
CY2016Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
55000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
716000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
136000
CY2017Q3 us-gaap Operating Expenses
OperatingExpenses
11231000
CY2016Q3 us-gaap Operating Expenses
OperatingExpenses
10333000
us-gaap Operating Expenses
OperatingExpenses
24280000
us-gaap Operating Expenses
OperatingExpenses
22385000
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
12248000
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
7731000
us-gaap Operating Income Loss
OperatingIncomeLoss
26664000
us-gaap Operating Income Loss
OperatingIncomeLoss
18131000
CY2017Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
249000
CY2016Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
23000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
490000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
76000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
8240000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
7784000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
350000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5859000
CY2017Q3 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
4
CY2017Q1 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
4
CY2017Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2017Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2017Q3 us-gaap Preferred Stock Value
PreferredStockValue
9000
CY2017Q1 us-gaap Preferred Stock Value
PreferredStockValue
9000
CY2017Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1106000
CY2017Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1019000
CY2017Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
29456000
CY2017Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
30164000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
46000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
352000
CY2017Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
96341000
CY2017Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
86530000
CY2017Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
66711000
CY2016Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
60791000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
146368000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
133278000
us-gaap Share Based Compensation
ShareBasedCompensation
1146000
us-gaap Share Based Compensation
ShareBasedCompensation
946000
CY2017Q3 us-gaap Stockholders Equity
StockholdersEquity
104323000
CY2017Q1 us-gaap Stockholders Equity
StockholdersEquity
93366000
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0
us-gaap Treasury Stock Shares Retired
TreasuryStockSharesRetired
0
us-gaap Treasury Stock Shares Retired
TreasuryStockSharesRetired
0
us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Use of Estimates</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:18pt;">The preparation of Condensed Consolidated Financial Statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Condensed Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</div></div></div></div>
CY2017Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20437000
CY2016Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20377000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20442000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20355000
CY2017Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20349000
CY2016Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20234000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20321000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20208000

Files In Submission

Name View Source Status
0001437749-17-017912-index-headers.html Edgar Link pending
0001437749-17-017912-index.html Edgar Link pending
0001437749-17-017912.txt Edgar Link pending
0001437749-17-017912-xbrl.zip Edgar Link pending
ex_97642.htm Edgar Link pending
ex_97643.htm Edgar Link pending
ex_97644.htm Edgar Link pending
ex_97645.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
pets-20170930.xml Edgar Link completed
pets-20170930.xsd Edgar Link pending
pets-20170930_cal.xml Edgar Link unprocessable
pets-20170930_def.xml Edgar Link unprocessable
pets-20170930_lab.xml Edgar Link unprocessable
pets-20170930_pre.xml Edgar Link unprocessable
pets20170930_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending